A. Sonia Petronio1, MD; Cristina Giannini1*, MD, PhD; Marco De Carlo1; MD, PhD; Francesco Bedogni2, MD; Antonio Colombo3, MD; Corrado Tamburino4, MD, PhD; Silvio Klugmann5, MD; Arnaldo Poli6, MD; Fabio Guarracino7, MD; Marco Barbanti4, MD; Azeem Latib3, MD; Nedy Brambilla2, MD; Claudia Fiorina8, MD; Giuseppe Bruschi5, MD; Paola Martina
1. Cardiac Catheterization Laboratory, Cardiothoracic Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 2. Istituto Clinico Sant’Ambrogio, Milan, Italy; 3. Istituto Scientifico H. San Raffaele, Milan, Italy; 4. Division of Cardiology, Fer
Aims: Transcatheter aortic valve implantation (TAVI) represents a valid therapeutic alternative for patients with severe aortic stenosis at high surgical risk. However, there is no genera
No account yet?
Sign up for free!
Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
from PCRonline.com
general anaesthesialocal anaesthesiatranscatheter aortic valve implantation
Interventions for valvular diseaseTAVIVascular access and bleeding
Read next article
Transaortic transcatheter aortic valve implantation using the Lotus valve: first-in-man experience